


WorthlessViews
PremiumNASDAQ:GPRO is a strong brand name, but with a dying userbase / lack of growth. The company has no major turnaround planned, but the chart is interesting. The stock seems to be currently consolidating as the historical simple moving average (white line) is working its way down toward the price - which often leads to a jump. Another candidate for the Santa Claus...
Nucor NYSE:NUE , a US manufacture of steel and steel products, will likely capitalize on reduced foreign competition as tariffs become reality. The CEO also recently stated that the steelmaker's order backlog is the largest in its history and is increasing prices. So, while there is a potential for short-term downside as tariff "unknowns" are negotiated, the...
As one of the largest pharmaceutical companies in the world, Novartis NYSE:NVS is poised to grow well into 2027. It's trading at a 17x P/E, earnings are forecast to grow 7% per year, it has low debt, and has been raising its dividend over the past few years (3.8%). The price on the daily chart is nearing the historical simple moving average line and may be...
First, I'm not an " NYSE:AMC APE" and have zero interest in becoming one. Second, don't trade NYSE:AMC unless you are fully aware the investment could go to zero or the company may devalue your trade via share dilution or other means (i.e., don't simply do as I do or blindly follow anyone else's moves, for the matter). With that aside, I started a...
Ironwood Pharma NASDAQ:IRWD stock dropped ~89% in the past year due to disappointing Phase 3 Apraglutide trial results, FDA requiring an additional trial, weak Q1 2025 earnings (-$0.14 EPS vs. -$0.04 expected), high debt ($599.48M), and analyst downgrades. So why would I be interested in swing trading this company? The chart. The price has entered my "crash"...
eHealth NASDAQ:EHTH , the largest online private health insurance marketplace, may be undervalued. The book value is listed around $19 a share and it has a debt-to-equity of 0.07x (healthy), a quick ratio of 2.5 (strong liquidity, can cover liabilities), growing revenue since 2021 (over $500M in 2024), and insiders have recently bought shares/awarded options....
NASDAQ:OTLY : A pure technical analysis or future acquisition play. While the company is unprofitable and only has about 1 year left of cash, the bottom "may" be in... unless an offering is announced (tread lightly). But my historical simple moving average (SMA) is approaching the price. Typically, when this happens, there is a sudden jump in the price to "meet"...
Opendoor Technologies $NASDAQ:OPEN. This is purely a swing trade for a company that has been posting declining earnings and revenue since 2022 and does not anticipate becoming profitable in the next 3 years. Since the stock is now under $1, it's at-risk of being delisted from the Nasdaq. I am entering this play because there is a chance the recent price hit near...
Helen of Troy NASDAQ:HELE , owner of brands such as OXO, Hydro Flask, Osprey, Vicks, Olive & June, etc, has witnessed an immense decline in share price since its peak in 2021 when it hit just over $265. Now, trading in the $20s... Growth has been a problem for this company (now and future projections) and a major turnaround is needed. However, NASDAQ:HELE is...
Columbus McKinnon Corp NASDAQ:CMCO is a stock that is highly cyclical, moving in "boom and bust" cycles every 3-5 years. As indicated by its entry into my "crash" simple moving average area (currently between $11 and $13), it may be nearing the end of its bust cycle (time will tell). With a book value at $31, debt-to-equity of 0.6x (healthy), quick ratio over 1...
ATAI Life Sciences NASDAQ:ATAI , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is for a fast upward move. In anticipation of this move, ...
The stock price for Huntsman Corp NYSE:HUN , a manufacturer of organic chemical products, has dropped significantly since its peak in 2022 ($41.65). This was due to lower sales volumes, weak demand in construction and transportation, higher input costs, and European operational challenges, including a $75M hit from closing a German Maleic Anhydride facility....
Dollar Tree NASDAQ:DLTR has taken a massive hit to its stock price as low-income spenders are cutting back (recession red flag, anyone?). It recently touched my selected "crash" simple moving average area (white lines on the chart) and may take many years before true recovery occurs. However, the Director recently bought $150k+ in shares after this recent drop,...
Jack in the Box NASDAQ:JACK has taken a massive hit to its stock price since its peak in 2024 at just over $124 a share. It's currently trading around $18 and has entered my "crash" simple moving average zone. More often than not, this area signifies a bottom (or future bounce), but I view it more as a consolidation area to accumulate shares. Float = 18M; short...
Sleep Number Company $NASDAQ:SNBR. Closed all existing open price gaps on the daily chart below its current rice. The overall downward trend is starting to flatten. They make all their products in the US and have minimal exposure to international markets (reduced risk around tariffs). Understandably, recession risks are high and such a company would be impacted....
Wayfair $NYSE:W. Recession fears are valid. But long-term, once this company becomes truly profitable, this will be a multi-bagger. I won't go on much about the fundamentals because there are too many economic unknowns ahead, but from a technical analysis perspective, the historical simple moving average lines/area is repeatedly converging with the price and...
Regeneron Pharmaceuticals NASDAQ:REGN stock dropped more than 17% today due to mixed Phase 3 trial results for itepekimab, a potential COPD drug. However, the company has an extensive drug pipeline, raked in over $14 billion last year, and is currently trading at a price-to-earnings of 15x. Debt-to-equity is 0.09x (extremely healthy) and earnings are forecast to...
SelectQuote NYSE:SLQT is currently resting within my historical simple moving average zone. This often signals consolidation and a future move (in this case, let's hope up). Looking at the company's financials, NYSE:SLQT is currently profitable. For Q3 2025 (ended March 31, 2025), the company reported a net income of $26.0 million, up from $8.6 million in Q3...